Research
Search
Close
HUANG Xiuyan
- Chief Physician, Researcher, Associate Professor
- Department: General Surgery
- Research Area: Surgery (General Surgery)
- Research Interests: Primary liver cancer; Secondary liver cancer; Circulating tumor cells; CAMLs
- Contact: xyhuang1119@163.com
- Postdoctoral fellow, Harvard Medical School, BWH & Dana-Farber Cancer Institute, 2015
- MD from Fudan University, School of Medicine, 2008
- Leader of the Hepatobiliary & Pancreatic Professional Group, Department of General Surgery, Shanghai Sixth People's Hospital
- Huang XY#, Li F, Li TT, Zhang JT, Shi XJ, Huang XY, Zhou J, Tang ZY, Huang ZL#. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma [J]. J Nanobiotechnology, 2023, 21(1):25. doi: 10.1186/s12951-023-01783-9.
- Huang ZL, Zhang PB, Zhang JT, Li F, Li TT, Huang XY#. Comprehensive genomic profiling identifies FAT1 as a negative regulator of EMT, CTCs, and metastasis of hepatocellular carcinoma [J]. J Hepatocell Carcinoma, 2023, 10:369-382. doi: 10.2147/JHC.S398573.
- Huang XY#, Zhang JT, Li F, Li TT, Shi XJ, Huang J, Huang XY, Zhou J, Tang ZY, Huang ZL#. Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC [J]. Hepatol Commun, 2023, 7(1):e0006. doi: 10.1097/HC9.0000000000000006.
- Huang ZL, Li F, Zhang JT, Shi XJ, Xu YH, Huang XY#. Research on the construction of bispecific-targeted sustained-release drug-delivery microspheres and their function in treatment of hepatocellular carcinoma [J]. ACS Omega, 2022, 7(25): 22003-22014. doi: 10.1021/acsomega.2c02584.
- Huang XY#, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, Zhou J, Tang ZY. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis [J]. J Exp Clin Cancer Res, 2020, 39(1): 20. doi: 10.1186/s13046-020-1529-9.
- Computer software copyright (2021SR0131052): Integrated management software system for anti-cancer drug preparation process V1.0
